With 4,000+ new cases, Delhi’s COVID tally rises to 2,25,796

On Monday, Delhi's Deputy Chief Minister Manish Sisodia said that he has tested positive for coronavirus.

With 4,000+ new cases, Delhi's COVID tally rises to 2,25,796

Coronavirus update: The total number of coronavirus cases in Delhi has increased to 2,25,796 after 4,263 new positive cases were reported from the national capital on Tuesday evening.

Delhi recorded 36 new COVID deaths taking the death toll to 4,806. The total numbers of active and recovered cases are 29,787, and 1,91,203, respectively.

On Monday, Delhi’s Deputy Chief Minister Manish Sisodia said that he has tested positive for coronavirus.

Also Read | Delhi allows reopening of Gyms, Yoga centres from today

He said in a tweet: “After having a mild fever, the corona test was conducted, whose report has come positive. I have kept myself in quarantine. Right now, there is no fever or any other problem, I am completely fine. Soon after getting all your blessings, I will return to work.”

Coronavirus Chandigarh Update

Delhi Health Minister Satyendar Jain stated that Delhi’s mortality rate in the past ten days has fallen to 0.68 percent compared to 3.5 to 4.5 percent at one point, following the right strategy.

Also Read | Lok Sabha clears MPs perks bill

On Monday, Delhi Chief Minister Arvind Kejriwal during the Delhi Legislative assembly session said that “Delhi has shown the way to the world on corona management in more than one way.”

As COVID-19 cases spike, Delhi faces ICU bed crisis again

Coronavirus in India

Rajesh Bhushan, Secretary, Union Health Ministry, while briefing media, said “There are 14 states and UTs in India where the total number of active cases are less than 5,000. There are 18 states and UTs where total active cases are between 5000-50,000.”

The country’s average positivity rate is 8.4 percent, he said.

Also Read | How COVID-19 pandemic has affected ‘sports jobs’ in India?

What about the COVID-19 vaccine?

Prof (Dr.) Balram Bhargava, DG, ICMR, said that “3 vaccines are at the clinical trial stage in India. Cadila and Bharat Biotech have completed phase-I trials. Serum Institute has completed phase II-B3 trials, and will start phase-III trial (with 1500 patients at 14 locations) after clearances.”

-PTC News